Experimental Therapy for Rare ALS Tested
Mayo Clinic researchers reported early findings from an experimental treatment designed for a single patient with a rare genetic form of amyotrophic lateral sclerosis (ALS).
Mayo Clinic researchers reported early findings from an experimental treatment designed for a single patient with a rare genetic form of amyotrophic lateral sclerosis (ALS).
A national analysis warns that surgeon supply will fall short of patient demand, with thoracic surgery and rural healthcare delivery facing steep deficits.
The American Lung Association’s 2023 "State of Lung Cancer" report reveals improvement in five-year survival rate across the US, including for people of color.
A study indicates pediatric asthma patients with a common gene variant may experience diminished response to mepolizumab during viral infections.
October is RSV Awareness Month, and the American Lung Association is promoting an educational initiative highlighting the threat of severe illness and hospitalization in older Americans.
The Sepsis ImmunoScore is the first sepsis artificial intelligence diagnostic tool authorized by the FDA and uses patient data to assess risk within 24 hours.
There are 1,180 US counties without a general surgeon, and more than 15 million Americans reside in these areas.
New 3D modeling reveals that unsteady airflow over the soft palate drives loud snoring sounds, pointing toward targeted therapies.